On the afternoon of May 19th, in the conference hall of Dunwill Medical's new headquarters building, the 2023 Shanghai G60 Medical New Economy Forum, with the theme of "release the synergy of smart ecology," effectively linked multiple intelligent forces such as industry, academia, research, government, and enterprises, gathered industry-leading enterprises, well-known investors, and senior industry research experts for in-depth dialogue, analyzed market trends in detail, and discussed the opportunities and challenges faced by the new economy and new healthcare.

The forum session was hosted by Zhou Jian, Vice President of Zhongshan Hospital affiliated to Fudan University. First of all, Fan Jia, an academician of the CAS and president of the Zhongshan Hospital affiliated to Fudan University, made a keynote speech around the theme of "scientific and technological innovation leads the high-quality development of public hospitals" from the three directions of the history of scientific and technological innovation of Zhongshan Hospital, the Zhongshan practice of scientific and technological innovation driving high-quality development, and the new journey of national medical center leading high-quality development, and described the grand blueprint of high-quality medical development. The report was brilliant and varied, and received enthusiastic responses from the attending guests.

Fan Jia, an Academician of the CAS and President of the Zhongshan Hospital affiliated to Fudan University

Zhou Jian, Vice President of Zhongshan Hospital affiliated to Fudan University

Subsequently, Mr. Zhang Jun, Managing Director of CITIC Securities, analyzed the current situation of the medical and health industry in the capital market and the path of A-share listing of medical device enterprises under the theme of "Analysis of Medical Device Enterprise Listing under the Comprehensive Registration System". Since the establishment of the Science and Technology Innovation Board, medical device companies have achieved rapid growth in listing. He believe that with the assistance of capital, the cooperation between industry, academia, research, and medical administration will undoubtedly stimulate innovative vitality and create more diagnostic and therapeutic products to serve modern medicine.

Mr. Zhang Jun, Managing Director of CITIC Securities

Dr. Shen Feng, Dean of the Clinical Research Institute of Shanghai Oriental Hepatobiliary Surgery Hospital, presented a brilliant report on individualized treatment of intrahepatic cholangiocarcinoma. His team established the world's first individualized prognosis scoring system for intrahepatic cholangiocarcinoma, using column charts as individualized treatment decision-making tools, and conducted research on designing different intrahepatic cholangiocarcinoma surgical plans based on different etiologies.

Dr. Shen Feng, Dean of the Clinical Research Institute of Shanghai Oriental Hepatobiliary Surgery Hospital

Finally, Hu Zhihua, the head of the Technology Progress Department of the Songjiang District Economic Commission in Shanghai, introduced the development situation and policies of the biopharmaceutical industry in Songjiang District. The biopharmaceutical industry is an important component of the "6+X" new industry in Songjiang District, and the completion of Dunwill Medical Headquarters in Songjiang will also stimulate industrial innovation vitality and promote the development of the biopharmaceutical industry in Songjiang with a pragmatic approach.

Hu Zhihua, the Head of the Technology Progress Department of the Songjiang District Economic Commission, Shanghai

After the baptism of the epidemic, the Chinese medical industry is currently in an important strategic opportunity period to promote the construction of a healthy China. Technological innovation is an important support for achieving the great goal of the Healthy China 2030 plan. The transformation and upgrading of the pharmaceutical and medical device industries require the production of a large number of patented drugs, new traditional Chinese medicine drugs, new formulations, high-end medical diagnosis and treatment equipment, and in vitro diagnostic reagents with independent intellectual property rights and international competitiveness. The core behind it is to improve the collaborative innovation system of government, industry, academia, research and application.

At this forum, representatives of various industry associations, experts and scholars representatives of well-known enterprises focused on the theme of "Building a Collaborative Innovation System for Medical Care in the New Era" and discussed at a roundtable. Guests attending included Sun Zhan, Vice President of Shanghai Geriatrics Center, Hou Yingyong, Director of Pathology Department of Zhongshan Hospital affiliated with Fudan University, Song Zhenju, Director of Research Department of Zhongshan Hospital affiliated with Fudan University, He Pengzhi, Senior Director of Diagnosis Department of Roche Diagnostics, Xue Xitian, Deputy General Manager of Shanghai Lingang United Development Co., Ltd., and investment partner of Tongchuang Weiye Liu Yimin, Director of China Resources Biotechnology. The guests shared their own positioning in the collaborative innovation ecosystem, as well as the challenges they face in achieving this "co-construction, sharing, and win-win" process. The exciting discussion has brought new ideas to the development of the industry and put forward constructive suggestions on how to create a medical collaborative innovation system.

Round Table Discussion

The 2023 Shanghai G60 Medical New Economy Forum has successfully concluded. In the future, Dunhui Medical will continue to cultivate the ecosystem, promote the aggregation and development of related industries in the upstream and downstream of biopharmaceuticals, assist in building a close cooperation and coordinated development model of medical new economy innovation, promote the medical industry ecosystem centered on G60, and create a higher quality and sustainable development of medical new economy ecosystem.